USADA announced today that Jordan Oliver, of Tempe, Ariz., an athlete in the sport of wrestling, has accepted a one-year suspension for an anti-doping rule violation.
Oliver, 27, tested positive for amphetamine as the result of an in-competition urine sample he provided at the U.S. Open World Team Trials on April 29, 2017. Amphetamine is a Non-Specified substance in the class of Stimulants and is prohibited in-competition under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic Committee National Anti-Doping Policies, and the United World Wrestling Anti-Doping Rules, all of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List.
Following notification of his positive test, Oliver informed USADA that he used a medication at least five days prior to the competition to treat a medical condition. After reviewing the specific medication and the concentration of amphetamine detected in Oliver’s sample, USADA determined the low amphetamine concentration was consistent with medication use five or more days before the competition. Oliver has since applied for a TUE to authorize his continued use of the stimulant medication.
Athletes are advised that the use of a substance or medication out-of-competition, that is prohibited only in-competition, may result in an anti-doping rule violation if the prohibited substance is still present in their body when tested at a competition. If an athlete needs to use a medication prohibited in-competition, and they are nearing a competition, they are strongly encouraged to contact USADA to learn if they need a TUE.
Oliver’s one-year period of ineligibility began on April 29, 2017, the date his positive sample was collected. In addition, Oliver has been disqualified from all competitive results obtained on and subsequent to April 29, 2017, including forfeiture of any medals, points and prizes.
In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, USADA manages a drug reference hotline, Global Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.
Along with education and testing, robust anti-doping programs enable investigations stemming from tips and whistleblowers. USADA makes available a number of ways to report the abuse of performance-enhancing drugs in sport in an effort to protect clean athletes and promote clean competition. Any tip can be reported using the USADA Play Clean Tip Center, by email at playclean@usada.org, by phone at 1-877-Play Clean (1-877-752-9253) or by mail at the address below.
USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.
For more information or media inquiries, click here.